Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Endo

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Nephrology|November 7, 2012
Renoprotection by continuous erythropoietin receptor activator in puromycin aminonucleoside-induced nephrotic syndromeKen Aizawa, Satoshi Takeda, Yoshihito Tashiro, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 17, 2008
A highly active heterogeneous palladium catalyst supported on a synthetic adsorbentYasunari Monguchi, Yuki Fujita, Koichi Endo, et al.
Calcified Tissue International|November 24, 2018
Sequential Treatment with Eldecalcitol After PTH Improves Bone Mechanical Properties of Lumbar Spine and Femur in Aged Ovariectomized RatsSadaoki Sakai, Hiromi Hongo, Tomomaya Yamamoto, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 22, 2014
Vitamin D receptor signaling enhances locomotive ability in miceSadaoki Sakai, Miho Suzuki, Yoshihito Tashiro, et al.
Bone|August 19, 2015
Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized ratsSadaoki Sakai, Satoshi Takeda, Masanori Sugimoto, et al.
Calcified Tissue International|December 4, 2014
Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2β- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized ratsSatoshi Takeda, Susan Y Smith, Tatsuya Tamura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 15, 2012
22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathyMichinori Hirata, Ken-Ichi Serizawa, Ken Aizawa, et al.
Journal of the Neurological Sciences|September 16, 2003
Frontal lobe dysfunction caused by multiple lacunar infarction in community-dwelling elderly subjectsYuki Takashima, Hiroshi Yao, Hiroshi Koga, et al.
Journal of Pharmacological Sciences|April 4, 2015
Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formationKen Aizawa, Youko Takahari, Naoko Higashijima, et al.
Calcified Tissue International|March 2, 2017
Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized RatsSatoshi Takeda, Sadaoki Sakai, Keisuke Tanaka, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Nephrology|November 7, 2012
Renoprotection by continuous erythropoietin receptor activator in puromycin aminonucleoside-induced nephrotic syndromeKen Aizawa, Satoshi Takeda, Yoshihito Tashiro, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 17, 2008
A highly active heterogeneous palladium catalyst supported on a synthetic adsorbentYasunari Monguchi, Yuki Fujita, Koichi Endo, et al.
Calcified Tissue International|November 24, 2018
Sequential Treatment with Eldecalcitol After PTH Improves Bone Mechanical Properties of Lumbar Spine and Femur in Aged Ovariectomized RatsSadaoki Sakai, Hiromi Hongo, Tomomaya Yamamoto, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 22, 2014
Vitamin D receptor signaling enhances locomotive ability in miceSadaoki Sakai, Miho Suzuki, Yoshihito Tashiro, et al.
Bone|August 19, 2015
Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized ratsSadaoki Sakai, Satoshi Takeda, Masanori Sugimoto, et al.
Calcified Tissue International|December 4, 2014
Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2β- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized ratsSatoshi Takeda, Susan Y Smith, Tatsuya Tamura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 15, 2012
22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathyMichinori Hirata, Ken-Ichi Serizawa, Ken Aizawa, et al.
Journal of the Neurological Sciences|September 16, 2003
Frontal lobe dysfunction caused by multiple lacunar infarction in community-dwelling elderly subjectsYuki Takashima, Hiroshi Yao, Hiroshi Koga, et al.
Journal of Pharmacological Sciences|April 4, 2015
Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formationKen Aizawa, Youko Takahari, Naoko Higashijima, et al.
Calcified Tissue International|March 2, 2017
Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized RatsSatoshi Takeda, Sadaoki Sakai, Keisuke Tanaka, et al.
Pageof 4